A Double-Blinded, Randomized, Placebo-Controlled, Phase 2B Trial of IMC-1 for the Treatment of Fibromyalgia
Latest Information Update: 09 Dec 2024
At a glance
- Drugs Celecoxib/famciclovir (Primary)
- Indications Fibromyalgia
- Focus Registrational; Therapeutic Use
- Acronyms FORTRESS
- Sponsors Dogwood Therapeutics; Virios Therapeutics
Most Recent Events
- 30 Oct 2024 According to Virios Therapeutics media release, Virios Therapeutics has changed its name to Dogwood Therapeutics.
- 29 Nov 2022 According to a Virios Therapeutics media release, Greg Duncan, Chairman and CEO of the company will be attending and presenting at the Planet MicroCap Showcase. The presentation will focus on the post-hoc analysis from this study.
- 25 Sep 2022 Status changed from active, no longer recruiting to completed.